Cargando…

P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

Detalles Bibliográficos
Autores principales: Duarte, D., Duarte, S., Sol dos Reis, C., Silva Coelho, P., Leite, L., Branca, R., Roncon, S., Pinho Vaz, C., Campos, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430321/
http://dx.doi.org/10.1097/01.HS9.0000848208.53297.5e